Active Trials

These COVID-19 clinical trials are active and approved by Health Canada. Many more are pending approval and will be added in the days and weeks ahead.

Help us complete the circle. Add your trial to our list of active COVID-19 Canadian clinical trials and gain access to a wider participant registry.

Trial name An International, Multicenter, randomized, double-blind, placebo-controlled, Phase III study evaluating the efficacy and safety of dapagliflozin in respiratory failure in patients with COVID-19
Type of trial Phase III
Trial ID NCT04350593
Health Canada Status Health Canada approved
Trial Status Pending
Location
Unknown
Trial description

To see if dapagliflozan will prevent serious complications and death in people who are hospitalized with COVID-19. Study participants will receive dapagliflozan or placebo.

Study team
Trial name Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)
Type of trial Phase III
Trial ID NCT04362137
Health Canada Status Health Canada approved
Trial Status Open
Location
Unknown
Trial description

To assess the effectiveness and safety of ruxolitinib in the treatment of adult patients with COVID-19 pneumonia.

Study team